Nonconventional glucagon and GLP-1 receptor agonist and antagonist interplay at the GLP-1 receptor revealed in high-throughput FRET assays for cAMP

Medicine & Life Sciences

• Glucagon-Like Peptide-1 Receptor 95%
• Glucagon 77%
• Glucagon-Like Peptide 1 31%
• neuropeptide Y2 receptor 22%
• exendin (9-39) 22%
• N-((4-(1-(3-(3,5-dichlorophenyl)-5-(6-methoxynaphthalen-2-yl)-1H-pyrazol-1-yl)ethyl)phenyl)carbonyl)-beta-alanine 15%
• G-Protein-Coupled Receptors 13%
• Peptide YY 9%
• Islets of Langerhans 6%
• Peptides 4%

Chemical Compounds

• Glucagon 100%
• Agent Interacting With Transmitter, Hormone or Drug Receptor 82%
• Agonist 25%
• Antagonist 18%
• Peptide YY 11%
• Glucagon-Like Peptide 1 10%
• Molecular Modeling 6%
• Protein 5%
• Dose 5%
• Peptide 3%